The AstraZeneca share price has fallen almost 25% since late August. Is there value on offer for investors after this huge fall? The post The AstraZeneca share price just fell 8.4% in a day. Is it ...
AstraZeneca's shares have fallen more than 8% on speculation about an anti-corruption probe in China, its second-largest ...
AstraZeneca shares dropped Tuesday after a report that dozens of the company’s senior executives in China potentially have ...
Astra saw £14.4bn wiped off its value after Chinese media said dozens of managers were implicated in a scandal.
Chinese authorities are investigating dozens of senior AstraZeneca (AZN) China executives amid an ongoing insurance fraud case, Yicai Global ...
The FTSE 100 was dented by a hefty fall for AstraZeneca after reports from China that dozens of the pharmaceutical company’s ...
AstraZeneca's (NASDAQ:AZN) selloff on Tuesday in response to reports that the company is facing a fraud investigation in ...
AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...
AstraZeneca shares fell 8% in London Tuesday, the biggest drop in four years following a fresh report that a Chinese investigation of the company has widened. AstraZeneca said last week that its China ...
AstraZeneca said on Tuesday that it does not comment on speculative media reports, in response to a sharp drop in its share ...
AstraZeneca PLC on Tuesday took the rare step of addressing a sharp fall in the company's share price. Shares in the Cambridge-based pharmaceuticals company slumped 8.2% to 10,138.10 pence each in ...
Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback